McMaster Textbook of Internal Medicine

Noninvasive treatment in PAD

2020-08-04

Sonia Anand

Recorded at the 5th McMaster International Review Course in Internal Medicine (MIRCIM).

Dr Sonia Anand is a professor in the Division of Cardiology, associate chair of Equity and Diversity in the Department of Medicine, Canada Research Chair in Ethnic Diversity and Cardiovascular Disease, and director of the Population Genomics Program at McMaster University.

Could you comment on noninvasive treatment options in patients with peripheral artery disease (PAD)?

Sonia Anand, MD, PhD: With noninvasive [treatment] we could manage 85% of patients, I hope. The problem with PAD in North America is that patients with PAD are undertreated. Although they should be nonsmokers, on a statin, on an angiotensin-converting enzyme inhibitor (ACEI), on aspirin, and maybe on low-dose rivaroxaban, the registry study shows that maybe only 50% of PAD patients are well treated.

I think that noninvasive management is to really focus on those risk factors and on treating them well. With that, patients with PAD can prevent the progression of the disease and maybe avoid surgery, as well as prevent and lower the risk of major adverse cardiovascular events.

See also

Invasive treatment in PAD Could you comment on invasive treatment options in patients with peripheral artery disease (PAD)?
Diagnostic workup of PAD by nonvascular specialists Do you have any suggestions or recommendations on diagnostic workup of peripheral artery disease (PAD) performed by a general practitioner or another nonvascular specialist?
Diagnosis and management of increased ferritin A lecture by Dr Mark Crowther, from McMaster University, Canada, delivered at McMaster International Review Course in Internal Medicine (MIRCIM) in May 2019.
Treating patients with peripheral artery disease in 2019 A lecture by Dr Sonia Anand, from McMaster University, Canada, delivered at McMaster International Review Course in Internal Medicine (MIRCIM) in May 2019.
Revascularization in older patients with chronic limb ischemia Should revascularization procedures in chronic limb ischemia be limited in older patients depending on their age or performance status?
Duration of dual antiplatelet therapy after PCI What should be the duration of dual antiplatelet therapy in patients after percutaneous coronary interventions (PCIs)?
Peripheral artery disease. Part 1: General management and COMPASS Dr Sonia Anand, professor in McMaster University's Department of Medicine, discusses general management of peripheral vascular disease in the context of the COMPASS trial.

We would love to hear from you

Comments, mistakes, suggestions?

We use cookies to ensure you get the best browsing experience on our website. Refer to our Cookies Information and Privacy Policy for more details.